183 Immuno-Oncology Companies Raised $46 Billion

Attempts to harness the immune system to fight cancer date back to the late 1800s. It has been less than 40 years since the first of these immuno-oncology therapies demonstrated success and obtained approval. Since then, nearly 40 cancer immunotherapies have received FDA approval. These approved treatments fall into five categories of immunotherapy: cell-based, immunomodulators […] READ MORE

$18 Billion Invested in 135 Cell Therapy Companies

Cell therapy was born in the 1930s when Paul Niehans earned the title of “father of cell therapy” by injecting the cells of animal organs into patients with numerous conditions including cancer. Although cell therapy was discovered nearly a century ago, new advances and techniques have caused a large increase in life science cell therapy […] READ MORE

Life Science Companies Pivot To Fight COVID-19

Doctors, scientists, health officials, world leaders and regular citizens around the globe breathed a collective sigh of relief late last year as vaccines to combat COVID-19 became a reality. The end of 2020 and beginning of 2021 presented three approved vaccines in the U.S., and distribution of those vaccines began shortly after their validation. READ MORE